Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2).
Saved in:
| Title: | Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2). |
|---|---|
| Authors: | Riselli AM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Yee SW; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Yang J; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Brett CM; Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California, USA., Trumbach K; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Zhou X; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Liu R; Drug Metabolism, Gilead Sciences Inc., Foster City, California, USA., Liang X; Drug Metabolism, Gilead Sciences Inc., Foster City, California, USA., Lai Y; Drug Metabolism, Gilead Sciences Inc., Foster City, California, USA., Huo R; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey, USA., Xue Y; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey, USA., Shen H; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey, USA., Zhang L; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Yang X; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Liu Q; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Huang SM; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Giacomini KM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Jul; Vol. 118 (1), pp. 177-189. Date of Electronic Publication: 2025 Apr 01. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
